Keyword: Novartis

News

Bayer’s Eylea AMD Drug Hits Cost Evaluation Hurdle

06.01.2014 - Bayer HealthCare has hit a stumbling block in the sales campaign for its new drug Eylea (aflibercept), or VEGF Trap-Eye, recommended for treatment of age-related wet macula...

News

EU Fines Drugmakers €16 million for Painkiller Delay

13.12.2013 - The European Commission has fined U.S. pharmaceutical producer Johnson & Johnson (J&J) €10.8 million and Swiss drugmaker Novartis of Switzerland € 5.5 million for actions taken by...

News

Boehringer Unit Taps Bank of America to Explore Sale of Generics Business

04.12.2013 - Ben Venue Laboratories, a Bedford, Ohio-based subsidiary of German drugmaker Boehringer Ingelheim has tapped Bank of America Merrill Lynch to explore a possible sale of its generic...

News

Novartis Overhauls Japanese Unit after Drug Scandal

07.10.2013 - Novartis said it had overhauled management operations and sanctioned key staff in Japan after a scandal involving research into its Diovan blood pressure drug in the country. The...

News

Astrazeneca CEO Gets Two Cheers after First Year in Job

01.10.2013 - Fixing ailing drugmaker AstraZeneca remains a work in progress for Chief Executive Pascal Soriot, with sales and profits still heading firmly downhill after his first year in the...

News

Syngenta May Be Template as Novartis Reviews Non-Core Assets

24.09.2013 - Novartis may take a leaf out of its past deal-book as the Swiss drugmaker conducts a review into some of its underperforming businesses, a board member said. New chairman Joerg...

News

Novartis to Investigate Bribery Claims at Alcon Unit in China

19.09.2013 - Novartis said it would investigate allegations published in a Chinese newspaper that its eye care unit Alcon bribed doctors. The 21st Century Business Herald, citing a...

News

China to Launch Fresh Pharmaceutical Bribery Probe

15.08.2013 - China is intensifying its investigation into rampant bribery in the pharmaceutical and medical services sector with a fresh three-month probe slated to begin on Thursday, the...